DeepSeek's $74B Raise, Instinct's Agent Bet & Industrial Capital Shifts
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
DeepSeek's $74B Raise, Instinct's Agent Bet & Industrial Capital Shifts
-
ナレーター：
-
著者：
(00:01:14) Instinct's $2.5B Agent Bet
(00:02:11) Healthcare Capital Clustering
(00:02:51) Industrial Investors Shortening Distribution
(00:03:30) Key Watchpoints
DeepSeek's $7.4B raise at a $74 billion pre-money valuation is the defining story of this cycle — not because the number is large, but because of what it contradicts. The efficiency narrative that made DeepSeek famous turns out to be a launchpad, not a destination. The company is now planning one gigawatt of compute expansion, backed by CATL, CPE, and Legend Capital. Efficient models don't eliminate capital intensity. They accelerate it.
Meanwhile, Instinct — the consumer AI agent still in private beta — jumped from a $500M Series A to a $2.5B Series B in weeks, led by Index Ventures and Benchmark. The product has no public monetisation model, and a recent incident involving an unauthorised restaurant booking exposed a fundamental gap: there is no defined liability framework for agent errors at scale. That's not a footnote. It's the core business risk.
Beyond the headline raises, today's briefing tracks a quieter structural shift. AusperBio closed $120M for a hepatitis B Phase 3 trial. Lupin Dental raised €15M for dental robotics in France. Agentrys pulled in $24.5M with MediaTek participating. CivilGrid closed a $26M Series A backed by Energy Impact Partners. PsiBot's embodied AI round topped $100M with Ningbo Tuopu and Lens Technology on the cap table.
The pattern: industrial insiders — not traditional VCs — are writing cheques into specialised startups, shortening distribution cycles rather than chasing headline valuations. Capital is clustering around technical depth and regulatory moats, from biotech to chip design to underground infrastructure.
Two watchpoints: whether DeepSeek's 2027 Shanghai listing survives geopolitical friction around U.S. chip export controls, and whether Instinct builds any liability framework before it scales. The market is pricing optimism. Execution will price reality.
This episode includes AI-generated content.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません